Agency News

⚡Novavax COVID-19 Vaccine Results Are Promising, Hope US-Based Company Starts Trial on Children Soon


In May this year the company had said that it has initiated a pediatric expansion of its Phase 3 clinical trial for its COVID vaccine candidate The additional arm of the ongoing PREVENT-19 pivotal trial will evaluate the efficacy, safety and immunogenicity of NVX-CoV2373 in up to 3,000 adolescents aged 12-17 across up to 75 sites in the US.

Read Full Story